Offerings // BeOne Medicines Ltd.

ONC offering history

Every offering-related filing in BeOne Medicines Ltd.’s recent SEC record — registrations (announced capacity) kept separate from pricing documents (executed sales). Reviewed 1,000 filings back to Aug 13, 2018.

Last executed offering

May 13, 2025

8-K — priced deal (shares or notes)

Last registration (announced)

May 6, 2026

S-3ASR — capacity, not a sale

Executed, last 12 months

424B pricings + 8-K 3.02 sales

Registered, last 12 months

S-1/S-3/F-series registrations

Date	Filing		What it means
May 6, 2026	S-3ASR →	REGISTERED	Automatic shelf registration — effective immediately (large filers)
May 6, 2026	S-3ASR →	REGISTERED	Automatic shelf registration — effective immediately (large filers)
Jun 2, 2025	EFFECT →	EFFECTIVE	SEC declared a registration effective — selling can begin
May 23, 2025	EFFECT →	EFFECTIVE	SEC declared a registration effective — selling can begin
May 13, 2025	8-K →	EXECUTED	Unregistered share sale disclosed (8-K item 3.02)
Mar 10, 2025	424B3 →	UPDATE	Prospectus update — often a resale registration, not necessarily new capital
Mar 7, 2025	EFFECT →	EFFECTIVE	SEC declared a registration effective — selling can begin
May 9, 2023	S-3ASR →	REGISTERED	Automatic shelf registration — effective immediately (large filers)
May 9, 2023	S-3ASR →	REGISTERED	Automatic shelf registration — effective immediately (large filers)
Dec 1, 2021	424B5 →	EXECUTED	Shelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm)
Nov 23, 2021	424B5 →	EXECUTED	Shelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm)
Dec 2, 2020	424B7 →	UPDATE	Resale prospectus — existing holders registering to sell
Dec 1, 2020	424B7 →	UPDATE	Resale prospectus — existing holders registering to sell
Sep 24, 2020	8-K →	EXECUTED	Unregistered share sale disclosed (8-K item 3.02)
Jul 13, 2020	424B2 →	EXECUTED	Prospectus supplement priced — shares or notes (large filers: often a bond deal)
May 11, 2020	S-3ASR →	REGISTERED	Automatic shelf registration — effective immediately (large filers)
May 11, 2020	S-3ASR →	REGISTERED	Automatic shelf registration — effective immediately (large filers)
Mar 17, 2020	8-K →	EXECUTED	Unregistered share sale disclosed (8-K item 3.02)
Jan 2, 2020	8-K →	EXECUTED	Unregistered share sale disclosed (8-K item 3.02)
Dec 6, 2019	8-K →	EXECUTED	Unregistered share sale disclosed (8-K item 3.02)
Oct 31, 2019	8-K →	EXECUTED	Unregistered share sale disclosed (8-K item 3.02)

ONC offering-related filings from SEC EDGAR, newest first (capped at 40). Each links to the original document.

Two honest limits. (1) A 424B takedown can price shares or notes— EDGAR’s metadata doesn’t say which, so open the document: large investment-grade filers use these mostly for bond deals (no dilution), small-caps mostly for shares. (2) At-the-market (ATM) programs sell shares gradually and individual sales are not separately filed — the visible footprint is the enabling shelf and its 424B5; actual ATM share counts surface later in the 10-Q/10-K share count. Educational information from public filings, not investment advice.

Is a shelf active now? →Do they need money? →Red flags →Full ONC workspace →

ONC offering FAQ

When did ONC last execute an offering?

Per SEC filings, BeOne Medicines Ltd.'s most recent priced offering document is a 8-K filed 2025-05-13. Note a 424B takedown can price shares or notes (debt) — the linked document says which.

When did ONC last announce or register an offering?

The most recent registration is a S-3ASR filed 2026-05-06. A registration is capacity to sell shares — not a sale.

Does an offering always mean dilution?

Registered direct offerings and shelf takedowns issue new shares and dilute existing holders. Resale registrations (424B3/B7) let existing holders sell and do not create new shares. Secondary sales by insiders also do not dilute. Each row here is labeled with what it is.